Reduced lung cancer incidence attributable to decreased tobacco use in urban Shanghai

被引:5
作者
Hu, Mu [1 ]
Wang, Youxin [2 ,3 ]
Zhang, Yi [1 ]
Zhi, Xiuyi [1 ]
机构
[1] Capital Med Univ, Xuanwu Hosp, Dept Thorac Surg, Beijing 100053, Peoples R China
[2] Capital Med Univ, Sch Publ Hlth, Beijing Municipal Key Lab Clin Epidemiol, Beijing 100069, Peoples R China
[3] Edith Cowan Univ, Sch Med Sci, Perth, WA 6027, Australia
基金
中国国家自然科学基金;
关键词
Lung cancer; Joinpoint Regression Program; Smoking; Tobacco control; JOINPOINT REGRESSION; UNITED-STATES; SMOKING; MORTALITY; DEATHS; RATES; CHINA;
D O I
10.1007/s10552-013-0269-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung cancer has been the most common type of cancer in the world for several decades, and by 2008, there were approximately 1.61 million new cases, representing 12.7 % of all new cancers. It has been well known for many years that smoking causes lung cancer. Tobacco control measures have been regarded as the principal causes of the declines in smoking-related mortality, including mortality from lung cancer. The Joinpoint Regression Program was used to analyze the long-term trends in lung cancer incidence rates from 1983 to 2008 in urban Shanghai. In addition, this study estimates how many fewer cases of lung cancer have occurred in urban Shanghai because of tobacco control activities. The lung cancer incidence rate among males decreased slightly by 0.6 % [95 % confidence interval (95 % CI) -0.1 to 1.3 %] from 1983 to 1999 and then declined rapidly at a rate of 3.8 % (95 % CI 2.1-5.4 %). Among females, the cancer incidence rate decreased by 0.1 % (95 % CI -0.2 to 0.5 %) from 1983 to 2008. Overall, we estimated that approximately 2,711 cases of lung cancer were averted among urban men in Shanghai between 2000 and 2008 because of the reduction in tobacco smoking. The reduction in tobacco smoking is a major factor in the decrease in the incidence rate of lung cancer. Sustained progress in tobacco control is essential.
引用
收藏
页码:2021 / 2025
页数:5
相关论文
共 26 条
  • [1] [Anonymous], 1103 US DHEW PHS ADV, P1103
  • [2] Armour B. S., 2005, Morbidity and Mortality Weekly Report, V54, P625
  • [3] Global estimates of cancer prevalence for 27 sites in the adult population in 2008
    Bray, Freddie
    Ren, Jian-Song
    Masuyer, Eric
    Ferlay, Jacques
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (05) : 1133 - 1145
  • [4] Joinpoint regression analysis of lung cancer mortality, Andalusia 1975-2000
    Cayuela, A
    Rodríguez-Domínguez, S
    López-Campos, JL
    Candelera, RO
    Matutes, CR
    [J]. ANNALS OF ONCOLOGY, 2004, 15 (05) : 793 - 796
  • [5] Center for Health Statistics and Information Ministry of Health of China & China Health Services Research, 2004, 3 NAT HLTH SERV SURV
  • [6] Evaluation on the incidence, mortality and tendency of lung cancer in China
    Chen, Wanqing
    Zhang, Siwei
    Zou, Xiaonong
    [J]. THORACIC CANCER, 2010, 1 (01) : 35 - 40
  • [7] A STUDY OF THE AETIOLOGY OF CARCINOMA OF THE LUNG
    DOLL, R
    HILL, AB
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1952, 2 (4797): : 1271 - 1286
  • [8] Mortality in relation to smoking: 50 years' observations on male British doctors
    Doll, R
    Peto, R
    Boreham, J
    Sutherland, I
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7455): : 1519 - 1528
  • [9] Trends in cigarette smoking in the United States
    Garfinkel, L
    [J]. PREVENTIVE MEDICINE, 1997, 26 (04) : 447 - 450
  • [10] Smoking prevalence among women in the European Community 1950-1990
    Graham, H
    [J]. SOCIAL SCIENCE & MEDICINE, 1996, 43 (02) : 243 - 254